{"count": 5, "results": [{"_id": "32039724", "pmid": 32039724, "pmcid": "PMC7008569", "title": "Cognitive function in metformin exposed children, born to mothers with PCOS - follow-up of an RCT", "journal": "BMC Pediatr", "authors": ["Greger HK", "Hanem LGE", "Østgård HF", "Vanky E"], "date": "2020-02-10T00:00:00Z", "doi": "10.1186/s12887-020-1960-2", "meta_date_publication": "2020 Feb 10", "meta_volume": "20", "meta_issue": "1", "meta_pages": "60", "score": 50255.066, "text_hl": "Association between @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@ and @<m>DISEASE_Developmental_Disabilities</m> @DISEASE_MESH:D002658 @@@developmental delay@@@ in offspring, and larger head circumference of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-exposed newborns has been reported. ", "citations": {"NLM": "Greger HK, Hanem LGE, Østgård HF, Vanky E. Cognitive function in metformin exposed children, born to mothers with PCOS - follow-up of an RCT BMC Pediatr. 2020 Feb 10;20(1):60. PMID: 32039724", "BibTeX": "@article{32039724, title={Cognitive function in metformin exposed children, born to mothers with PCOS - follow-up of an RCT}, author={Greger HK and Hanem LGE and Østgård HF and Vanky E}, journal={BMC Pediatr}, volume={20}, number={1}, pages={60}}"}}, {"_id": "40499703", "pmid": 40499703, "title": "Protective effects of metformin against volatile organic compounds-induced developmental toxicity in zebrafish embryos.", "journal": "Comp Biochem Physiol C Toxicol Pharmacol", "authors": ["Lu J", "Li Z", "Ruan X", "Jin L", "Yu X", "Zhou X", "Zhao J", "Wu Y", "Chen S", "Sun K", "Sun J"], "date": "2025-06-09T00:00:00Z", "doi": "10.1016/j.cbpc.2025.110250", "meta_date_publication": "2025 Jun 9", "meta_volume": "296", "meta_issue": "", "meta_pages": "110250", "score": 50243.258, "text_hl": "Our findings demonstrate @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@'s anti-apoptotic protection against @CHEMICAL_Volatile_Organic_Compounds @CHEMICAL_MESH:D055549 @@@VOCs@@@-induced developmental @DISEASE_Drug_Related_Side_Effects_and_Adverse_Reactions @DISEASE_MESH:D064420 @@@toxicity@@@, suggesting its potential as a novel therapeutic intervention for pollution-related @<m>DISEASE_Developmental_Disabilities</m> @DISEASE_MESH:D002658 @@@developmental disorders@@@.", "citations": {"NLM": "Lu J, Li Z, Ruan X, Jin L, Yu X, Zhou X, Zhao J, Wu Y, Chen S, Sun K, Sun J. Protective effects of metformin against volatile organic compounds-induced developmental toxicity in zebrafish embryos. Comp Biochem Physiol C Toxicol Pharmacol. 2025 Jun 9;296():110250. PMID: 40499703", "BibTeX": "@article{40499703, title={Protective effects of metformin against volatile organic compounds-induced developmental toxicity in zebrafish embryos.}, author={Lu J and Li Z and Ruan X and Jin L and Yu X and Zhou X and Zhao J and Wu Y and Chen S and Sun K and Sun J}, journal={Comp Biochem Physiol C Toxicol Pharmacol}, volume={296}, pages={110250}}"}}, {"_id": "28727687", "pmid": 28727687, "pmcid": "PMC5775940", "title": "Hippocampus-dependent memory and allele-specific gene expression in adult offspring of alcohol-consuming dams after neonatal treatment with thyroxin or metformin", "journal": "Mol Psychiatry", "authors": ["Tunc-Ozcan E", "Wert SL", "Lim PH", "Ferreira A", "Redei EE"], "date": "2018-07-01T00:00:00Z", "doi": "10.1038/mp.2017.129", "meta_date_publication": "2018 Jul", "meta_volume": "23", "meta_issue": "7", "meta_pages": "1643-1651", "score": 50040.434, "text_hl": "The present results indicate that @CHEMICAL_Thyroxine @CHEMICAL_MESH:D013974 @@@T4@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, administered during the neonatal period that is equivalent to the third trimester of @SPECIES_9606 @@@human@@@ pregnancy, are potential treatments for @DISEASE_Fetal_Alcohol_Spectrum_Disorders @DISEASE_MESH:D063647 @@@FASD@@@ and conceivably for other @<m>DISEASE_Developmental_Disabilities</m> @DISEASE_MESH:D002658 @@@neurodevelopmental disorders@@@ with @DISEASE_Cognition_Disorders @DISEASE_MESH:D003072 @@@cognitive deficits@@@.", "citations": {"NLM": "Tunc-Ozcan E, Wert SL, Lim PH, Ferreira A, Redei EE. Hippocampus-dependent memory and allele-specific gene expression in adult offspring of alcohol-consuming dams after neonatal treatment with thyroxin or metformin Mol Psychiatry. 2018 Jul;23(7):1643-1651. PMID: 28727687", "BibTeX": "@article{28727687, title={Hippocampus-dependent memory and allele-specific gene expression in adult offspring of alcohol-consuming dams after neonatal treatment with thyroxin or metformin}, author={Tunc-Ozcan E and Wert SL and Lim PH and Ferreira A and Redei EE}, journal={Mol Psychiatry}, volume={23}, number={7}, pages={1643-1651}}"}}, {"_id": "29103210", "pmid": 29103210, "title": "Insulin for the treatment of women with gestational diabetes.", "journal": "Cochrane Database Syst Rev", "authors": ["Brown J", "Grzeskowiak L", "Williamson K", "Downie MR", "Crowther CA"], "date": "2017-11-05T00:00:00Z", "doi": "10.1002/14651858.CD012037.pub2", "meta_date_publication": "2017 Nov 5", "meta_volume": "11", "meta_issue": "11", "meta_pages": "CD012037", "score": 50016.19, "text_hl": "There was no clear evidence of difference in postnatal weight retention between @SPECIES_9606 @@@women@@@ treated with @GENE_INS @GENE_3630 @@@insulin@@@ and those treated with oral anti-@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ pharmacological therapy (@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@) at six to eight weeks postpartum (MD -1.60 kg, 95% CI -6.34 to 3.14; one study, 167 @SPECIES_9606 @@@women@@@; low-quality evidence) or one year postpartum (MD -3.70, 95% CI -8.50 to 1.10; one study, 176 @SPECIES_9606 @@@women@@@; low-quality evidence). ", "citations": {"NLM": "Brown J, Grzeskowiak L, Williamson K, Downie MR, Crowther CA. Insulin for the treatment of women with gestational diabetes. Cochrane Database Syst Rev. 2017 Nov 5;11(11):CD012037. PMID: 29103210", "BibTeX": "@article{29103210, title={Insulin for the treatment of women with gestational diabetes.}, author={Brown J and Grzeskowiak L and Williamson K and Downie MR and Crowther CA}, journal={Cochrane Database Syst Rev}, volume={11}, number={11}, pages={CD012037}}"}}, {"_id": "24606795", "pmid": 24606795, "title": "Mitochondrial biogenesis: pharmacological approaches.", "journal": "Curr Pharm Des", "authors": ["Valero T"], "date": "2014-01-01T00:00:00Z", "doi": "10.2174/138161282035140911142118", "meta_date_publication": "2014", "meta_volume": "20", "meta_issue": "35", "meta_pages": "5507-9", "score": 50010.22, "text_hl": "@DISEASE_Mitochondrial_Diseases @DISEASE_MESH:D028361 @@@Mitochondrial dysfunctions@@@ are the prime source of @DISEASE_Neurodegenerative_Diseases @DISEASE_MESH:D019636 @@@neurodegenerative diseases@@@ and @<m>DISEASE_Developmental_Disabilities</m> @DISEASE_MESH:D002658 @@@neurodevelopmental disorders@@@. ", "citations": {"NLM": "Valero T. Mitochondrial biogenesis: pharmacological approaches. Curr Pharm Des. 2014;20(35):5507-9. PMID: 24606795", "BibTeX": "@article{24606795, title={Mitochondrial biogenesis: pharmacological approaches.}, author={Valero T}, journal={Curr Pharm Des}, volume={20}, number={35}, pages={5507-9}}"}}]}